Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate‐dose cyclophosphamide-Reference-Cited by-同舟云学术

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate‐dose cyclophosphamide

Published:1997-07 Issue:1 Volume:98 Page:228-233
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

McQuaker I. G.¹,Haynes A. P.¹²,Stainer C.¹,Anderson S.¹,Russell N. H.¹²

Affiliation:

1. Department of Haematology, Nottingham City Hospital NHS Trust,

2. Division of Haematology, Department of Clinical Laboratory Sciences, University of Nottingham, Nottingham

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.1997.1812998.x

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma Patients;Journal of Clinical and Experimental Hematopathology;2016

2. Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation;Journal of Clinical Apheresis;2014-06-19

3. Mobilization of Peripheral Blood Stem Cells for Autologous Transplantation in Patients with Hematologic Malignancies;Laboratory Medicine Online;2014

4. Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs;British Journal of Haematology;2013-10-21

5. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation;Blood;2010-05-06